Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Disorders of the Male Reproductive System01:20

Disorders of the Male Reproductive System

Men's health issues are increasingly recognized as significant, with several conditions posing common threats. Among these, testicular cancer is especially prevalent in younger men, particularly those aged 20 to 35 years. The disease often manifests as a painless mass in the testicles, sometimes accompanied by a sensation of heaviness or a dull ache.
Prostate disorders are another major concern. These conditions can impair urinary flow due to the prostate's location around the urethra. Symptoms...
Testosterone: Functions and Regulation01:26

Testosterone: Functions and Regulation

The intricate hormonal interplay essential for male reproductive health begins with the release of gonadotropin-releasing hormone (GnRH) by the hypothalamus. This hormone prompts the pituitary gland to secrete follicle-stimulating hormone (FSH) and luteinizing hormone (LH). LH targets the Leydig cells in the testes, stimulating them to produce and release testosterone. In concert with testosterone, FSH acts on the Sertoli cells within the seminiferous tubules to facilitate the release of...
Male Sexual Response: Erection & Ejaculation01:17

Male Sexual Response: Erection & Ejaculation

Sexual stimulation can take various forms, such as physical touch and visual or auditory cues. When this happens, the parasympathetic reflex in the sacral portion of the spinal cord is activated. This reflex stimulates the release of nitric oxide (NO), which then dilates the arterioles in the penis, increasing blood flow to the erectile tissues - the corpora cavernosa and corpus spongiosum.
The blood filling the erectile tissues compresses the veins, which helps to prevent blood from leaving...
Infertility in Males01:23

Infertility in Males

Male infertility affects millions of couples worldwide, arising from various factors that impact different stages of the reproductive process. An endocrine imbalance resulting from conditions like hypogonadism, Klinefelter syndrome, or pituitary disorders can disrupt hormone levels and reduce sperm production. Testicular defects, such as tumors, cryptorchidism, atrophic testes, abnormal sperm morphology, and low sperm count or motility, may arise due to genetic factors, structural...
Treatment for Pulmonary Arterial Hypertension: Phosphodiesterase Inhibitors01:28

Treatment for Pulmonary Arterial Hypertension: Phosphodiesterase Inhibitors

Phosphodiesterase 5 (PDE5) inhibitors are potent enzymes that function to hydrolyze cyclic nucleotides to their corresponding 5' monophosphates. Their unique biochemical properties have been applied in treating Pulmonary Arterial Hypertension (PAH).
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...
Signs of Puberty01:27

Signs of Puberty

Puberty is a critical phase, typically beginning between the ages of 8 and 13 in girls and 9 and 14 in boys, though timing can vary based on genetics, environmental factors, and overall health. This period is characterized by the development of secondary sexual characteristics and the attainment of reproductive potential. Endocrine changes underpin puberty, with hormonal surges of Luteinizing Hormone (LH) and Follicle-Stimulating Hormone (FSH) instigated by Gonadotropin-Releasing Hormone (GnRH)...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Does Testosterone Therapy Increase Risk of Atrial Fibrillation? Appraisal of the Contemporary Scientific and Clinical Evidence.

The world journal of men's health·2026
Same author

The association between age and mortality in men with adult-onset testosterone deficiency is altered by testosterone therapy.

The aging male : the official journal of the International Society for the Study of the Aging Male·2026
Same author

Effects of testosterone deficiency and therapy on the cardiometabolic syndrome in men.

The American journal of the medical sciences·2025
Same author

Testosterone therapy over 60 months improves aging male symptoms scores in all men with adult-onset testosterone deficiency.

The aging male : the official journal of the International Society for the Study of the Aging Male·2024
Same author

Recognizing the True Value of Testosterone Therapy in Health Care.

Androgens: clinical research and therapeutics·2023
Same author

Examining Male Predominance of Severe COVID-19 Outcomes: A Systematic Review.

Androgens: clinical research and therapeutics·2022

Related Experiment Videos

Testosterone and erectile dysfunction.

Aksam A Yassin1, Farid Saad

  • 1Clinic of Urology/Andrology, Segeberger Kliniken, Norderstedt-Hamburg, Germany. yassin@t-online.de

Journal of Andrology
|July 22, 2008
PubMed
Summary
This summary is machine-generated.

Low testosterone levels in men are linked to erectile dysfunction (ED). Testosterone therapy can improve erectile function and response to PDE-5 inhibitors, especially in hypogonadal men.

Related Experiment Videos

Area of Science:

  • Andrology
  • Urology
  • Endocrinology

Background:

  • Aging men experience declining libido and serum testosterone levels.
  • Androgen deficiency is associated with age-related conditions, including erectile dysfunction (ED).
  • Organic ED, often linked to atherosclerosis, affects approximately 70% of cases and shares risk factors with diabetes, hypercholesterolemia, and smoking.

Purpose of the Study:

  • To evaluate the role of testosterone therapy in managing ED.
  • To determine if testosterone therapy improves erectile function in men with ED and hypogonadism.
  • To assess the impact of testosterone therapy on the efficacy of phosphodiesterase-5 (PDE-5) inhibitors.

Main Methods:

  • Review of animal and clinical studies on testosterone therapy and ED.
  • Analysis of interventional studies in hypogonadal men with ED.
  • Examination of the relationship between testosterone levels and PDE-5 inhibitor response.

Main Results:

  • Testosterone therapy improves erectile function in hypogonadal men.
  • Testosterone therapy enhances the response to PDE-5 inhibitors in patients with ED and hypogonadism.
  • A eugonadal state is necessary for the full therapeutic potential of PDE-5 inhibitors.

Conclusions:

  • Testosterone therapy is a valuable option for men with ED and hypogonadism.
  • Measuring testosterone concentrations is recommended for all men presenting with ED.
  • Restoring eugonadal status optimizes ED treatment outcomes.